Alnylam Pharmaceuticals Inc (ALNY) Insider Trading
- $71,277,732.32
- $352,942,664.07
- Dec. 27, 2023
- Akshay Vaishnaw
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Jan. 29, 2015 | Major Shareholder | 97,118 | $95.00 | Buy | $9,226,210.00 | |
Jan. 26, 2015 | CEO | 10,000 | $95.00 | Buy | $950,000.00 | |
Jan. 26, 2015 | Director | 1,000 | $95.00 | Buy | $95,000.00 | |
Dec. 19, 2014 | COO | 11,200 | $100.00 | Sell | $1,120,000.00 | |
Dec. 16, 2014 | EVP | 10,626 | $93.60 | Sell | $994,593.60 | |
Dec. 15, 2014 | VP | 22,162 | $97.50 | Sell | $2,160,795.00 | |
Nov. 18, 2014 | SVP | 10,000 | $90.67 | Sell | $906,700.00 | |
Nov. 17, 2014 | COO | 33,200 | $89.63 | Sell | $2,975,716.00 | |
Oct. 28, 2014 | Director | 15,000 | $95.00 | Sell | $1,425,000.00 | |
Oct. 22, 2014 | Director | 5,000 | $90.00 | Sell | $450,000.00 | |
Oct. 13, 2014 | Director | 110,000 | $85.00 | Sell | $9,350,000.00 | |
Sept. 25, 2014 | Director | 90,000 | $78.09 | Sell | $7,028,100.00 | |
Sept. 24, 2014 | Director | 45,000 | $79.08 | Sell | $3,558,600.00 | |
Sept. 18, 2014 | CEO | 113,668 | $77.71 | Sell | $8,833,140.28 | |
Sept. 16, 2014 | EVP | 10,625 | $72.04 | Sell | $765,425.00 | |
Aug. 18, 2014 | SVP | 13,500 | $67.34 | Sell | $909,090.00 | |
June 26, 2014 | CEO | 113,668 | $65.45 | Sell | $7,439,570.60 | |
June 17, 2014 | EVP | 10,625 | $69.82 | Sell | $741,837.50 | |
May 21, 2014 | Director | 35,000 | $53.80 | Sell | $1,883,000.00 | |
May 19, 2014 | SVP | 13,500 | $57.83 | Sell | $780,705.00 | |
May 15, 2014 | CEO | 113,668 | $56.73 | Sell | $6,448,385.64 | |
March 25, 2014 | major shareholder | 344,448 | $66.88 | Buy | $23,036,682.24 | |
March 18, 2014 | EVP | 32,769 | $73.95 | Sell | $2,423,267.55 | |
Feb. 19, 2014 | SVP | 20,400 | $80.06 | Sell | $1,633,224.00 | |
Jan. 24, 2014 | EVP | 7,890 | $85.75 | Sell | $676,567.50 | |
Jan. 13, 2014 | Director | 15,000 | $85.36 | Sell | $1,280,400.00 | |
Dec. 20, 2013 | Director | 15,000 | $65.00 | Sell | $975,000.00 | |
Dec. 17, 2013 | EVP | 33,480 | $60.72 | Sell | $2,032,905.60 | |
Oct. 22, 2013 | Director | 15,000 | $60.00 | Sell | $900,000.00 | |
Sept. 11, 2013 | CEO | 58,947 | $55.50 | Sell | $3,271,558.50 | |
Sept. 10, 2013 | EVP | 6,250 | $57.48 | Sell | $359,250.00 | |
Aug. 14, 2013 | CEO | 60,000 | $48.97 | Sell | $2,938,200.00 | |
July 12, 2013 | VP | 14,200 | $50.00 | Sell | $710,000.00 | |
July 10, 2013 | CEO | 60,000 | $37.11 | Sell | $2,226,600.00 | |
July 1, 2013 | VP | 27,000 | $32.00 | Sell | $864,000.00 | |
June 17, 2013 | VP | 23,625 | $29.93 | Sell | $707,096.25 | |
June 11, 2013 | EVP | 15,000 | $31.08 | Sell | $466,200.00 | |
May 28, 2013 | SVP | 5,000 | $30.00 | Sell | $150,000.00 | |
May 28, 2013 | COO | 22,822 | $30.00 | Sell | $684,660.00 | |
March 26, 2013 | Director | 52,631 | $23.49 | Sell | $1,236,302.19 | |
Jan. 22, 2013 | Director | 4,967 | $20.13 | Buy | $99,985.71 |
Insiders are both buying and selling Alnylam Pharmaceuticals Inc stock.
The insider traders at Alnylam Pharmaceuticals Inc are: John Maraganore, Akshay Vaishnaw, Laurie Keating, Yvonne Greenstreet, Barry E Greene, Michael Mason, Paul Schimmel, Philip A Sharp, Laurence Reid, Sanofi, Steven M Paul, Pushkal Garg, Tolga Tanguler, Kevin P Starr, Dennis A Ausiello, Michael W Bonney, Indrani Lall Franchini, Jeffrey V Poulton, Phillip A Sharp, John Clarke, Kevin P. Starr, Marsha Fanucci, David E I Pyott, Philip A. Sharp, and David-Alexandre C Gros
The most active insider trader at Alnylam Pharmaceuticals Inc is John Maraganore with 23 trades.
John Maraganore has sold the most Alnylam Pharmaceuticals Inc stock with a total value of $118,340,674.92.
Sanofi has bought the most Alnylam Pharmaceuticals Inc stock with a total value of $89,326,528.48.
The most recent insider trade for Alnylam Pharmaceuticals Inc was on Dec. 27, 2023.
The single biggest insider buy for Alnylam Pharmaceuticals Inc was from Sanofi with a total value of $23,036,682.24 on March 25, 2014.
The single biggest insider sell for Alnylam Pharmaceuticals Inc was from Akshay Vaishnaw with a total value of $12,672,077.40 on March 14, 2018.